Niva Bupa Health Insurance Company Limited announced its unaudited financial results for the third quarter and nine months ended December 31, 2025. The company reported a Profit After Tax (PAT) of over ₹76 crore for Q3 FY26 and ₹208 crore for the nine-month period ending December 31, 2025. On a reported basis, Gross Written Premium (GWP) for Q3 FY26 grew by 55% year-on-year to ₹2,231 crore, compared to ₹1,442 crore in Q3 FY25. For the nine months of FY26, GWP stood at ₹5,706 crore, registering a 22% year-on-year growth. On a like-to-like basis (without the 1/n accounting impact), Q3 FY26 GWP increased by 32% to ₹2,327 crore, and 9M FY26 GWP reached ₹6,309 crore, reflecting a 26% year-on-year growth. The Combined Insurance Service Ratio (IFRS) for 9MFY26 improved by 0.51 percentage points year-on-year. The Claims Settlement Ratio stood at 94.1% for Q3 FY26 and 94.4% for 9M FY26. Niva Bupa's retail health market share rose by 1.4 percentage points to 10.2% in Q3 FY26. The customer base grew by 23% year-on-year, with the number of lives insured reaching 24.5 million. Net Promoter Score (NPS) improved to 59 for Q3 FY26, an increase of 3.4 points compared to the same quarter last year. For 9M FY26, NPS stood at 58, reflecting an improvement of 5.4 points over the same period last year. Krishnan Ramachandran, MD & CEO, Niva Bupa, commented that the Q3 FY26 performance reflects the strength of their growth strategy, increasing relevance in the retail health insurance market, and sustained focus on profitability. He reiterated the commitment to improving customer outcomes while building a resilient and profitable health insurance franchise.
